Human Herpesvirus-6B Reactivation Is a Risk Factor for Grades II to IV Acute Graft-versus-Host Disease after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
Open Access
- 21 April 2018
- journal article
- review article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 24 (11), 2324-2336
- https://doi.org/10.1016/j.bbmt.2018.04.021
Abstract
No abstract availableKeywords
Funding Information
- HHV-6 Foundation
This publication has 87 references indexed in Scilit:
- CD134 is a cellular receptor specific for human herpesvirus-6B entryProceedings of the National Academy of Sciences of the United States of America, 2013
- Human Herpesvirus 6 Infection after Hematopoietic Cell Transplantation: Is Routine Surveillance Necessary?Transplantation and Cellular Therapy, 2011
- Reduced Mortality after Allogeneic Hematopoietic-Cell TransplantationNew England Journal of Medicine, 2010
- Impact of Cytomegalovirus (CMV) Reactivation after Umbilical Cord Blood TransplantationTransplantation and Cellular Therapy, 2010
- Evaluation of NIH consensus criteria for classification of late acute and chronic GVHDBlood, 2009
- Immune regulation and control of regulatory T cells by OX40 and 4-1BBCytokine & Growth Factor Reviews, 2008
- CD134-Allodepletion Allows Selective Elimination of Alloreactive Human T Cells without Loss of Virus-Specific and Leukemia-Specific EffectorsTransplantation and Cellular Therapy, 2008
- OX40 costimulation turns off Foxp3+ TregsBlood, 2007
- High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCTBlood, 2006
- Activation-associated phenotype of CD3+ T cells in acute graft-versus-host diseaseClinical and Experimental Immunology, 2006